1 - 25 of 40 results for author:"Minegishi Y." in Literature citations
Results Customize
› Repeat search in UniProtKB (839)
| Inflammatory monocytes recruited to allergic skin acquire an anti-inflammatory M2 phenotype via basophil-derived interleukin-4. Egawa M., Mukai K., Yoshikawa S., Iki M., Mukaida N., Kawano Y., Minegishi Y., Karasuyama H. Immunity 38:570-580(2013) · Mapped (12) |
| Adaptor protein complex of FRS2beta and CIN85/CD2AP provides a novel mechanism for ErbB2/HER2 protein downregulation. Minegishi Y., Shibagaki Y., Mizutani A., Fujita K., Tezuka T., Kinoshita M., Kuroda M., Hattori S., Gotoh N. Cancer Sci. 104:345-352(2013) · Mapped (13) |
| First draft genome sequence of the Japanese eel, Anguilla japonica. Henkel C.V., Dirks R.P., de Wijze D.L., Minegishi Y., Aoyama J., Jansen H.J., Turner B., Knudsen B., Bundgaard M., Hvam K.L. et al. Gene 511:195-201(2012) · UniProtKB (75) |
| First-line gefitinib in patients aged 75 or older with advanced non-small cell lung cancer harboring epidermal growth factor receptor mutations: NEJ 003 study. Maemondo M., Minegishi Y., Inoue A., Kobayashi K., Harada M., Okinaga S., Morikawa N., Oizumi S., Tanaka T., Isobe H. et al. J Thorac Oncol 7:1417-1422(2012) · Mapped (19) |
| MiR-23a regulates TGF-beta-induced epithelial-mesenchymal transition by targeting E-cadherin in lung cancer cells. Cao M., Seike M., Soeno C., Mizutani H., Kitamura K., Minegishi Y., Noro R., Yoshimura A., Cai L., Gemma A. Int. J. Oncol. 41:869-875(2012) · Mapped (15) |
| Th2-inducing cytokines IL-4 and IL-33 synergistically elicit the expression of transmembrane TNF-alpha on macrophages through the autocrine action of IL-6. Ogawa H., Mukai K., Kawano Y., Minegishi Y., Karasuyama H. Biochem. Biophys. Res. Commun. 420:114-118(2012) · Mapped (10) |
| Primitive duplicate Hox clusters in the European eel's genome. Henkel C.V., Burgerhout E., de Wijze D.L., Dirks R.P., Minegishi Y., Jansen H.J., Spaink H.P., Dufour S., Weltzien F.A., Tsukamoto K. et al. PLoS ONE 7:e32231-e32231(2012) · UniProtKB (71) |
| Basophil-derived mouse mast cell protease 11 induces microvascular leakage and tissue edema in a mast cell-independent manner. Yamagishi H., Mochizuki Y., Hamakubo T., Obata K., Ugajin T., Sato S., Kawano Y., Minegishi Y., Karasuyama H. Biochem. Biophys. Res. Commun. 415:709-713(2011) · Mapped (4) |
| Defective IL-10 signaling in hyper-IgE syndrome results in impaired generation of tolerogenic dendritic cells and induced regulatory T cells. Saito M., Nagasawa M., Takada H., Hara T., Tsuchiya S., Agematsu K., Yamada M., Kawamura N., Ariga T., Tsuge I. et al. J. Exp. Med. 208:235-249(2011) · Mapped (6) |
| Selective ablation of basophils in mice reveals their nonredundant role in acquired immunity against ticks. Wada T., Ishiwata K., Koseki H., Ishikura T., Ugajin T., Ohnuma N., Obata K., Ishikawa R., Yoshikawa S., Mukai K. et al. J. Clin. Invest. 120:2867-2875(2010) · Mapped (18) |
| An atopic dermatitis-like skin disease with hyper-IgE-emia develops in mice carrying a spontaneous recessive point mutation in the Traf3ip2 (Act1/CIKS) gene. Matsushima Y., Kikkawa Y., Takada T., Matsuoka K., Seki Y., Yoshida H., Minegishi Y., Karasuyama H., Yonekawa H. J. Immunol. 185:2340-2349(2010) · UniProtKB (2) · Mapped (4) |
| Gefitinib or chemotherapy for non-small-cell lung cancer with mutated EGFR. Maemondo M., Inoue A., Kobayashi K., Sugawara S., Oizumi S., Isobe H., Gemma A., Harada M., Yoshizawa H., Kinoshita I. et al. N. Engl. J. Med. 362:2380-2388(2010) · Mapped (19) |
| Acid suppression by proton pump inhibitors enhances aquaporin-4 and KCNQ1 expression in gastric fundic parietal cells in mouse. Matsuzaki J., Suzuki H., Minegishi Y., Sugai E., Tsugawa H., Yasui M., Hibi T. Dig. Dis. Sci. 55:3339-3348(2010) · Mapped (10) |
| FRS2beta, a potential prognostic gene for non-small cell lung cancer, encodes a feedback inhibitor of EGF receptor family members by ERK binding. Iejima D., Minegishi Y., Takenaka K., Siswanto A., Watanabe M., Huang L., Watanabe T., Tanaka F., Kuroda M., Gotoh N. Oncogene 29:3087-3099(2010) · Mapped (1) |
| Hyper-IgE syndrome. Minegishi Y. Curr. Opin. Immunol. 21:487-492(2009) · Mapped (3) |
| Defects in Jak-STAT-mediated cytokine signals cause hyper-IgE syndrome: lessons from a primary immunodeficiency. Minegishi Y., Karasuyama H. Int. Immunol. 21:105-112(2009) · Mapped (14) |
| The skewed heavy-chain repertoire in peritoneal B-1 cells is predetermined by the selection via pre-B cell receptor during B cell ontogeny in the fetal liver. Yoshikawa S., Kawano Y., Minegishi Y., Karasuyama H. Int. Immunol. 21:43-52(2009) · Mapped (13) |
| Multiple population structure of the giant mottled eel, Anguilla marmorata. Minegishi Y., Aoyama J., Tsukamoto K. Mol. Ecol. 17:3109-3122(2008) · UniProtKB (16) |
| Basophils play a pivotal role in immunoglobulin-G-mediated but not immunoglobulin-E-mediated systemic anaphylaxis. Tsujimura Y., Obata K., Mukai K., Shindou H., Yoshida M., Nishikado H., Kawano Y., Minegishi Y., Shimizu T., Karasuyama H. Immunity 28:581-589(2008) · Mapped (4) |
| E-cadherin expression and epidermal growth factor receptor mutation status predict outcome in non-small cell lung cancer patients treated with gefitinib. Miyanaga A., Gemma A., Ando M., Kosaihira S., Noro R., Minegishi Y., Kataoka K., Nara M., Okano T., Miyazawa H. et al. Oncol. Rep. 19:377-383(2008) · Mapped (19) |
| Mast cells and basophils are selectively activated in vitro and in vivo through CD200R3 in an IgE-independent manner. Kojima T., Obata K., Mukai K., Sato S., Takai T., Minegishi Y., Karasuyama H. J. Immunol. 179:7093-7100(2007) · Mapped (9) |
| PTEN inactivation in lung cancer cells and the effect of its recovery on treatment with epidermal growth factor receptor tyrosine kinase inhibitors. Noro R., Gemma A., Miyanaga A., Kosaihira S., Minegishi Y., Nara M., Kokubo Y., Seike M., Kataoka K., Matsuda K. et al. Int. J. Oncol. 31:1157-1163(2007) · Mapped (3) |
| Enhanced ghrelin expression and subsequent acid secretion in mice with genetic H(2)-receptor knockout. Arakawa M., Suzuki H., Minegishi Y., Fukushima Y., Masaoka T., Ishikawa T., Hosoda H., Kangawa K., Hibi T. J. Gastroenterol. 42:711-718(2007) · Mapped (5) |
| Reduced Shh expression in TFF2-overexpressing lesions of the gastric fundus under hypochlorhydric conditions. Minegishi Y., Suzuki H., Arakawa M., Fukushima Y., Masaoka T., Ishikawa T., Wright N.A., Hibi T. J. Pathol. 213:161-169(2007) · Mapped (5) |
| Dominant-negative mutations in the DNA-binding domain of STAT3 cause hyper-IgE syndrome. Minegishi Y., Saito M., Tsuchiya S., Tsuge I., Takada H., Hara T., Kawamura N., Ariga T., Pasic S., Stojkovic O. et al. |